The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India

The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India

Context: The guideline recommended dose of intravenous (i.v) recombinant tissue-type plasminogen activator (rt-PA) for acute ischemic stroke is 0.9 mg/kg in the European and American populations. In Asiatic population, some studies have shown that a lower dose of i.v rt-PA is equally efficacious. Ai...

Full description

Bibliographic Details
Main Authors: Siju V Abraham, Fazil Thaha, S Vimal Krishnan, Athulya Shajan, Jayaraj Mymbilly Balakrishnan, Babu Urumese Palatty
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Acute ischemic stroke
dose optimization
India
recombinant tissue-plasminogen activator
thrombolysis
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2017;volume=20;issue=1;spage=36;epage=40;aulast=Abraham

Internet

http://www.annalsofian.org/article.asp?issn=0972-2327;year=2017;volume=20;issue=1;spage=36;epage=40;aulast=Abraham

Similar Items